Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1761 - 1767 of 1767 results

First page
Previous page
177
Next page disabled
Next page disabled

PARAFFIN

I9O0E3H2ZE

Status:

US Approved OTC

Source:

21 CFR 349.14(b)(3) ophthalmic:emollient paraffin

Source URL:

https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec349-14.xml

First marketed in 1921

Source:

Paraffin U.S.P.

Source URL:

https://www.gutenberg.org/files/41778/41778-h/41778-h.htm

Class:

STRUCTURALLY DIVERSE

LANOLIN

7EV65EAW6H

Status:

US Approved OTC

Source:

21 CFR 349.14(a)(2) ophthalmic:emollient lanolin (in combination)

Source URL:

https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec349-14.xml

First marketed in 1921

Source:

Hydrous Wool Fat U.S.P.

Source URL:

https://www.gutenberg.org/files/41778/41778-h/41778-h.htm

Class:

STRUCTURALLY DIVERSE

WHITE WAX

7G1J5DA97F

Status:

US Approved OTC

Source:

21 CFR 349.14(b)(7) ophthalmic:emollient wax, white

Source URL:

https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec349-14.xml

First marketed in 1921

Source:

White Wax U.S.P.

Source URL:

https://www.gutenberg.org/files/41778/41778-h/41778-h.htm

Class:

STRUCTURALLY DIVERSE

BIRCH TRITERPENES

BX09B0RQR0

Status:

US Approved Rx (2023)

Source:

NDA215064

(2023)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215064

First approved in 2020

Source:

21 CFR 333A

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be4e5a00-5749-e0f2-e053-2a95a90ac763

Class:

G1 SPECIFIED SUBSTANCE

EXEM FOAM KIT

WLT3PF2KX0

Status:

US Approved Rx (2019)

Source:

NDA212279

(2019)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212279

First approved in 2019

Source:

NDA212279

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212279

Class:

G1 SPECIFIED SUBSTANCE

ACP-001

5377795HRF

Status:

US Approved Rx (1995)

Source:

BLA020280

(1995)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020280

First approved in 1976

Source:

Asellacrin by Hoechst Roussel

Source URL:

OB NME Appendix 1950-1985

Class:

CONCEPT

PROTAMINE

72G3UY6T4N

Status:

US Approved Rx (1987)

Source:

ANDA089454

(1987)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=089454

First approved in 1950

Source:

PROTAMINE SULFATE by LILLY

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006460

Class:

CONCEPT

Structurally Diverse

PARAFFIN

Structurally Diverse

LANOLIN

Structurally Diverse

WHITE WAX

Concept

BIRCH TRITERPENES

Concept

Concept

ACP-001

Concept

PROTAMINE

Showing 1761 - 1767 of 1767 results

First page
Previous page
177
Next page disabled
Next page disabled

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1